EUVIMEDEUVIMED entdecken
Open Access

Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network

Katherine Adams iD, Zachary A Weber, Duck-Hye Yang, Nicola P Klein, Malini B DeSilva, Kristin Dascomb, Stephanie A Irving, Allison L Naleway, Suchitra Rao iD, Manjusha Gaglani iD, Brendan Flannery, Shikha Garg und 17 weitere

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciad704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Katherine Adams und 28 weiteren Autor:innen. Beteiligte Einrichtung: Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, Kaiser Foundation Hospitals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

During the 2022–2023 influenza season, the United States experienced the highest influenza-associated pediatric hospitalization rate since 2010–2011. Influenza A/H3N2 infections were predominant.

Methods

We analyzed acute respiratory illness (ARI)–associated emergency department or urgent care (ED/UC) encounters or hospitalizations at 3 health systems among children and adolescents aged 6 months–17 years who had influenza molecular testing during October 2022–March 2023. We estimated influenza A vaccine effectiveness (VE) using a test-negative approach. The odds of vaccination among influenza-A–positive cases and influenza-negative controls were compared after adjusting for confounders and applying inverse-propensity-to-be-vaccinated weights. We developed overall and age-stratified VE models.

Results

Overall, 13 547 of 44 787 (30.2%) eligible ED/UC encounters and 263 of 1862 (14.1%) hospitalizations were influenza-A–positive cases. Among ED/UC patients, 15.2% of influenza-positive versus 27.1% of influenza-negative patients were vaccinated; VE was 48% (95% confidence interval [CI], 44–52%) overall, 53% (95% CI, 47–58%) among children aged 6 months–4 years, and 38% (95% CI, 30–45%) among those aged 9–17 years. Among hospitalizations, 17.5% of influenza-positive versus 33.4% of influenza-negative patients were vaccinated; VE was 40% (95% CI, 6–61%) overall, 56% (95% CI, 23–75%) among children ages 6 months–4 years, and 46% (95% CI, 2–70%) among those 5–17 years.

Conclusions

During the 2022–2023 influenza season, vaccination reduced the risk of influenza-associated ED/UC encounters and hospitalizations by almost half (overall VE, 40–48%). Influenza vaccination is a critical tool to prevent moderate-to-severe influenza illness in children and adolescents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanInfluenza VaccinesAdolescentChildHumansUnited StatesInfluenza A Virus, H3N2 SubtypeSeasonsVaccine EfficacyHospitalizationVaccinationEmergency Service, HospitalHospitals

Stichwörter der Autor:innen

influenzapediatrictest-negative designvaccine effectiveness

Substanzen

Influenza Vaccines

Autor:innen und Institutionen

  • Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Department of Clinical Research, Westat, Rockville, Maryland, USA.
  • Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, California, USA.
  • Department of Research, HealthPartners Institute, Minneapolis, Minnesota, USA.
  • Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA.
  • Department of Science Programs, Kaiser Permanente Center for Health Research, Portland, Oregon, USA.

ORCID-Profile: Katherine Adams, Suchitra Rao, Manjusha Gaglani, Karthik Natarajan, Ousseny Zerbo, Mark W Tenforde

Förderung

  • Intramural CDC HHS
  • Kaiser Foundation Hospitals

Zitieren

APA

Adams, K., Weber, Z. A., Yang, D. H., Klein, N. P., DeSilva, M. B., Dascomb, K., Irving, S. A., Naleway, A. L., Rao, S., Gaglani, M., Flannery, B., Garg, S., Kharbanda, A. B., Grannis, S. J., Ong, T. C., Embi, P. J., Natarajan, K., Fireman, B., Zerbo, O., …, & Tenforde, M. W. (2024). Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad704

Vancouver

Adams K, Weber ZA, Yang DH, Klein NP, DeSilva MB, Dascomb K, et al. Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad704

BibTeX
@article{Adams2024,
  author = {Adams, Katherine and Weber, Zachary A and Yang, Duck-Hye and Klein, Nicola P and DeSilva, Malini B and Dascomb, Kristin and Irving, Stephanie A and Naleway, Allison L and Rao, Suchitra and Gaglani, Manjusha and Flannery, Brendan and Garg, Shikha and Kharbanda, Anupam B and Grannis, Shaun J and Ong, Toan C and Embi, Peter J and Natarajan, Karthik and Fireman, Bruce and Zerbo, Ousseny and Goddard, Kristin and Timbol, Julius and Hansen, John R and Grisel, Nancy and Arndorfer, Julie and Ball, Sarah W and Dunne, Margaret M and Kirshner, Lindsey and Chung, Jessie R and Tenforde, Mark W},
  title = {Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciad704}
}
Kostenlos starten →